Biotherapeutics Cell Line Development Market Global Industry Analysis, Size, Share, Growth, Trends and Forecast Research Report 2015 – 2022

Submitted by: Submitted by

Views: 10

Words: 1003

Pages: 5

Category: Business and Industry

Date Submitted: 01/29/2016 02:14 AM

Report This Essay

Researchmoz added Most up-to-date research on "Biotherapeutics Cell Line Development Market (by Process, CLD Option and by Geography): Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2015 - 2022" to its huge collection of research reports.

With the increasing number of recombinant protein therapeutics gaining approval by the U.S. Food and Drug Administration (FDA) annually, there is an increase in the demand of cell lines for production of these biotherapeutics. From 2006 to 2011 an average of 15 novel recombinant protein therapeutics and in 2014, 11 novel recombinant protein therapeutics have been approved by US FDA. About forty-seven monoclonal antibody products have been approved in the U.S., Europe and other global markets, of which over 60% were produced in mammalian cell culture.

Moreover, the rise in the geriatric population coupled with prevalence of diseases is one of the major factors driving the demand for cell line development for biotherapeutics. The increasing demand for monoclonal antibodies across the globe boosts the market growth. In addition, the increasing number of initiatives taken by the government of various countries by funding the life science research and development is expected to propel this market in coming years.

To Get Sample Copy of Report visit @ http://www.researchmoz.us/enquiry.php?type=S&repid=531402

The global biotherapeutics cell line development market is segmented by process, by cell line development option and by geography. The market by process segment has been sub-segmented as transfection and single cell cloning. The single cell cloning market is further sub-segmented by method into manual limited dilution cloning, FACS, ClonePix and Others. The market by CLD option is segmented as In-house, outsource, hybrid and do-it-yourself. The ClonePix accounted for the largest market share of 37.4% in 2014. Geographically, the market has been studied and estimated for five regions: North America,...